Powered by

Insulet's Omnipod® Horizon(TM) Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes

Jun 09, 2019 - Business Wire

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump  technology with its Omnipod® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the Omnipod® Horizon(TM) Automated Insulin Delivery System (Omnipod Horizon System) were presented during the  American Diabetes Association  (ADA) 79th Scientific Sessions in San Francisco, California. The study demonstrated that the inves...